Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
Re: question re comt inhibitors
At 23:38 1999/10/23 +0100, you wrote: >I wish someone coould make an authoritative statement on the ability of >Tolcapone and/or Entacapone to cross the blood/brain barrier. Janet has heard >that Tolcapone does, and Entacapone doesn't, while I am quite clear that I >was told some time ago (When Tolcapone was originally approved) that >Tolcapone cannot cross the barrier. I remember it well, because I asked my >friendly local neurologist how Tolcapone worked, and he confessed with >some embarrassment that he didn't know, because of the above inability to >cross into the brain. It may also be relevant that Tolcapone was withdrawn >because it caused liver failure (in a small number of people). i.e. in >the body, not the brain. > >-- >Brian Collins <bjc@xxxxxxxxxxxxxxx> > hi brian i posted 9 abstracts on the subject a few days ago they formed the basis for my comments janet janet paterson 52 now / 41 dx / 37 onset 613 256 8340 po box 171 almonte ontario canada K0A 1A0 a new voice: <> <janet313@xxxxxxxxxxx>
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance